Heritage Wealth Management (Arizona)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$962K Sell
6,742
-579
-8% -$76.7K 0.53% 42
2024
Q1
$940K Sell
7,321
-269
-4% -$32K 0.48% 47
2023
Q4
$785K Buy
+7,590
New +$751K 0.43% 54
2022
Q4
$140K Buy
2,068
+1,020
+97% +$59.8K 0.02% 372
2022
Q3
$52K Sell
1,048
-616
-37% -$33K 0.02% 393
2022
Q2
$92.7K Sell
1,664
-38
-2% -$2.11K 0.03% 344
2022
Q1
$95K Buy
+1,702
New +$87.3K 0.03% 374
2021
Q3
$94K Buy
1,960
+40
+2% +$1.93K 0.03% 354
2021
Q2
$80K Buy
1,920
+98
+5% +$3.8K 0.03% 377
2021
Q1
$61K Buy
+1,822
New +$64.9K 0.03% 342

Other funds holding NVO

Heritage Wealth Management (Arizona)'s NVO Position: Q2 2024 in Review

Heritage Wealth Management (Arizona) reduced its Novo Nordisk (NVO) stake by 7.9% in Q2 2024, selling an estimated $76.7K and leaving 6,742 shares worth $962K. The position accounts for 0.53% of the portfolio, ranked #42.

Heritage Wealth Management (Arizona) first reported a position in NVO in Q1 2021 and has held it in 10 quarters since. 1,864 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Heritage Wealth Management (Arizona) held 6,742 shares of Novo Nordisk worth $962K as of Q2 2024.
  • Heritage Wealth Management (Arizona) sold 579 Novo Nordisk shares in Q2 2024, an estimated $76.7K.
  • Novo Nordisk made up 0.53% of Heritage Wealth Management (Arizona)'s portfolio in Q2 2024, its #42 holding.
  • Heritage Wealth Management (Arizona) first reported a position in Novo Nordisk in Q1 2021 and has held it in 10 quarters since.
  • 1,864 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q2 2024, filed 30 Jul 2024.